High-output Fistula

Overview

Journal Clin Colon Rectal Surg

Date 2009 Dec 17

PMID 20011253

Citations 7

Authors

Naila Arebi

Alastair Forbes

Affiliations

Soon will be listed here.

Abstract

Despite improvements in healthcare delivery, mortality rates for high-output fistulae remain unchanged. The pathophysiology and causes of fistulae are reviewed in this article. An overview of the diagnostic procedures to delineate fistulae and underlying bowel disease together with their complications is included. Management of high-output fistulae consists of assessment and stabilization of patients, followed by conservative management by a multidisciplinary team until spontaneous or surgical closure of fistulae.

Citing Articles

Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.

Mordecai L, Reynolds C, Donaldson L, de C Williams A Br J Gen Pract. 2018; 68(668):e225-e233.

PMID: 29440012 PMC: 5819988. DOI: 10.3399/bjgp18X695057.

Management of Intestinal Failure: The High-Output Enterostomy and Enterocutaneous Fistula.

Adaba F, Vaizey C, Warusavitarne J Clin Colon Rectal Surg. 2017; 30(3):215-222.

PMID: 28684940 PMC: 5498185. DOI: 10.1055/s-0037-1598163.

Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.

Martinez-Ordaz J, Bosco-Garate I, Cerbulo-Vazquez A, Arriaga-Pizano L, Wong-Baeza I, Sanchez-Fernandez P J Gastrointest Surg. 2016; 21(3):453-462.

PMID: 27909869 DOI: 10.1007/s11605-016-3333-6.

Metabolic and nutritional support of the enterocutaneous fistula patient: a three-phase approach.

Polk T, Schwab C World J Surg. 2011; 36(3):524-33.

PMID: 22033622 DOI: 10.1007/s00268-011-1315-0.

Historical perspectives in the care of patients with enterocutaneous fistula.

Lundy J, Fischer J Clin Colon Rectal Surg. 2011; 23(3):133-41.

PMID: 21886462 PMC: 2967312. DOI: 10.1055/s-0030-1262980.

References

Zera R, Bubrick M, Sternquist J, HITCHCOCK C . Enterocutaneous fistulas. Effects of total parenteral nutrition and surgery. Dis Colon Rectum. 1983; 26(2):109-12. DOI: 10.1007/BF02562587. View

Sitges-Serra A, Jaurrieta E . Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg. 1982; 69(3):147-50. DOI: 10.1002/bjs.1800690310. View

Bruley des Varannes S, Levy P, Lartigue S, Dellatolas F, Lemaire M, Galmiche J . Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther. 1994; 8(3):309-14. DOI: 10.1111/j.1365-2036.1994.tb00293.x. View

Maconi G, Sampietro G, Parente F, Pompili G, Russo A, Cristaldi M . Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn's disease: a prospective comparative study. Am J Gastroenterol. 2003; 98(7):1545-55. DOI: 10.1111/j.1572-0241.2003.07521.x. View

Alexander E, Weinberg S, Clark R, Belkin R . Fistulas and sinus tracts: radiographic evaluation, management, and outcome. Gastrointest Radiol. 1982; 7(2):135-40. DOI: 10.1007/BF01887627. View

Jobling C, Halligan S, Bartram C . The use of non-ionic water-soluble contrast agents for small bowel follow-through examination. Eur Radiol. 1999; 9(4):706-10. DOI: 10.1007/s003300050737. View

Frost S . Stoma care: managing high-output fistulas. Nurs Stand. 1991; 5(51):25-7. View

Pederzoli P, Bassi C, Falconi M, Albrigo R, Vantini I, Micciolo R . Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion of somatostatin, glucagon or calcitonin. Surg Gynecol Obstet. 1986; 163(5):428-32. View

Bell S, Halligan S, Windsor A, Williams A, Wiesel P, Kamm M . Response of fistulating Crohn's disease to infliximab treatment assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2003; 17(3):387-93. DOI: 10.1046/j.1365-2036.2003.01427.x. View

10.

Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G . Transabdominal bowel sonography for the detection of intestinal complications in Crohn's disease. Gut. 1998; 44(1):112-7. PMC: 1760075. DOI: 10.1136/gut.44.1.112. View

11.

Read N, Cooper K, Fordtran J . Effect of modified sham feeding on jejunal transport and pancreatic and biliary secretion in man. Am J Physiol. 1978; 234(4):E417-20. DOI: 10.1152/ajpendo.1978.234.4.E417. View

12.

Ysebaert D, Van Hee R, Hubens G, Vaneerdeweg W, Eyskens E . Management of digestive fistulas. Scand J Gastroenterol Suppl. 1994; 207:42-4. DOI: 10.3109/00365529409104194. View

13.

McIntyre P, Ritchie J, HAWLEY P, Bartram C, Lennard-Jones J . Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg. 1984; 71(4):293-6. DOI: 10.1002/bjs.1800710416. View

14.

Katz P, Hatlebakk J, Castell D . Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000; 14(6):709-14. DOI: 10.1046/j.1365-2036.2000.00775.x. View

15.

Maconi G, Parente F, Bianchi Porro G . Hydrogen peroxide enhanced ultrasound- fistulography in the assessment of enterocutaneous fistulas complicating Crohn's disease. Gut. 1999; 45(6):874-8. PMC: 1727746. DOI: 10.1136/gut.45.6.874. View

16.

Koelbel G, Schmiedl U, Majer M, Weber P, Jenss H, Kueper K . Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging. AJR Am J Roentgenol. 1989; 152(5):999-1003. DOI: 10.2214/ajr.152.5.999. View

17.

Kidd M, Modlin I, Tang L . Gastrin and the enterochromaffin-like cell: an acid update. Dig Surg. 1998; 15(3):209-17. DOI: 10.1159/000018616. View

18.

Londong W, Londong V, Cederberg C, Steffen H . Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology. 1983; 85(6):1373-8. View

19.

OKeefe S, Haymond M, Bennet W, Oswald B, Nelson D, SHORTER R . Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies. Gastroenterology. 1994; 107(2):379-88. DOI: 10.1016/0016-5085(94)90162-7. View

20.

Rieber A, Nussle K, Reinshagen M, Brambs H, Gabelmann A . MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging. 2002; 27(4):394-9. DOI: 10.1007/s00261-001-0120-x. View